
A 2026 FDA AEMS E2B(R3) cutover runbook covering the October 1 deadline, applicability, R2 transformation risks, ESG NextGen testing, acknowledgements, validation, and hypercare.
IntuitionLabs is now a member of the Claude Partner Network – AI training and upskilling with Claude for pharma and biotech. Book a call.

A 2026 FDA AEMS E2B(R3) cutover runbook covering the October 1 deadline, applicability, R2 transformation risks, ESG NextGen testing, acknowledgements, validation, and hypercare.

An in-depth guide to the ICH E2B(R3) standard for pharmacovigilance. Explore the data structure of ICSRs, electronic reporting rules, and key global systems. Updated April 2026.

An overview of AI agents in pharmacovigilance (PV), covering agentic AI, generative AI, and ML applications in safety data processing, ICSR management, and signal detection, with updates on the CIOMS WG XIV final report, FDA's Elsa tool, and EU AI Act requirements.
© 2026 IntuitionLabs. All rights reserved.